1. Home
  2. APLM vs ZKIN Comparison

APLM vs ZKIN Comparison

Compare APLM & ZKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • ZKIN
  • Stock Information
  • Founded
  • APLM 2016
  • ZKIN 2015
  • Country
  • APLM United States
  • ZKIN China
  • Employees
  • APLM N/A
  • ZKIN 281
  • Industry
  • APLM Blank Checks
  • ZKIN Metal Fabrications
  • Sector
  • APLM Finance
  • ZKIN Industrials
  • Exchange
  • APLM Nasdaq
  • ZKIN Nasdaq
  • Market Cap
  • APLM 7.7M
  • ZKIN 6.5M
  • IPO Year
  • APLM N/A
  • ZKIN 2017
  • Fundamental
  • Price
  • APLM $6.16
  • ZKIN $1.05
  • Analyst Decision
  • APLM Strong Buy
  • ZKIN
  • Analyst Count
  • APLM 2
  • ZKIN 0
  • Target Price
  • APLM $425.00
  • ZKIN N/A
  • AVG Volume (30 Days)
  • APLM 42.6K
  • ZKIN 18.9K
  • Earning Date
  • APLM 04-15-2025
  • ZKIN 01-01-0001
  • Dividend Yield
  • APLM N/A
  • ZKIN N/A
  • EPS Growth
  • APLM N/A
  • ZKIN N/A
  • EPS
  • APLM N/A
  • ZKIN N/A
  • Revenue
  • APLM $2,101,000.00
  • ZKIN $108,199,877.00
  • Revenue This Year
  • APLM N/A
  • ZKIN N/A
  • Revenue Next Year
  • APLM N/A
  • ZKIN N/A
  • P/E Ratio
  • APLM N/A
  • ZKIN N/A
  • Revenue Growth
  • APLM 70.54
  • ZKIN N/A
  • 52 Week Low
  • APLM $6.20
  • ZKIN $0.29
  • 52 Week High
  • APLM $63.00
  • ZKIN $3.18
  • Technical
  • Relative Strength Index (RSI)
  • APLM 42.37
  • ZKIN 37.39
  • Support Level
  • APLM $6.50
  • ZKIN $1.30
  • Resistance Level
  • APLM $8.00
  • ZKIN $1.35
  • Average True Range (ATR)
  • APLM 1.36
  • ZKIN 0.11
  • MACD
  • APLM -0.22
  • ZKIN -0.01
  • Stochastic Oscillator
  • APLM 5.93
  • ZKIN 0.00

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

Share on Social Networks: